Linkage Biosciences Closes Growth Capital and Inks Distribution Partners
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 05/07/13 -- Linkage Biosciences, a molecular diagnostics company and leader in Human Leukocyte Antigen (HLA) typing and associated products, announced that it recently raised $2 million in growth capital. The financing was led by Fisher Capital Corp LLC with all major investors from previous rounds also participating including Greenhouse Capital Partners and Big Sky Partners.
"We are seeing a marked increase in demand for the LinkS?q™ product line," said Zachary Antovich, the company's Chief Executive Officer. "Our focus on quality and delivering winning solutions to the HLA community has generated a loyal and passionate user base. This financing will help accelerate our efforts around the world."
Linkage Bioscience's LinkS?q HLA product line uses a proprietary software and chemistry platform in conjunction with real-time PCR instrumentation to deliver results faster and simpler than any other system on the market.
In addition to the financing, Linkage announced several new distribution partners including GenDx Products (Benelux countries), INyDIA Diagnostica (Spain and Portugal), Commugene (South Korea), and Ortner Medical Supplies (Austria).
"Each of these companies possesses a history of excellent customer service and proven technical expertise, particularly in the area of HLA testing," continued Mr. Antovich. "We are looking forward to working with our new partners as we expand into these territories."
Linkage Biosciences, Inc. is a privately held molecular diagnostics company developing and marketing products that dramatically improve and expedite complex genetic testing. The company's LinkS?q HLA testing product line is used in the fields of histocompatibility and immunogenetics. To learn more please visit .
LinkS?q is for Research Use Only.
Copyright 2013. Linkage Biosciences, Inc. All rights reserved.
Linkage Biosciences and LinkS?q are trademarks of Linkage Biosciences, Inc.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.05.2013 - 12:00 Uhr
Sprache: Deutsch
News-ID 256867
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 289 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Linkage Biosciences Closes Growth Capital and Inks Distribution Partners"
steht unter der journalistisch-redaktionellen Verantwortung von
Linkage Biosciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
